WOLVERINE TRADING, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$421,000
+41.8%
13,000
+31.3%
0.00%
Q4 2021$297,000
+40.1%
9,900
+47.8%
0.00%
Q2 2021$212,000
-79.4%
6,700
-82.9%
0.00%
-100.0%
Q1 2021$1,027,000
+95.6%
39,241
+28.2%
0.00%
-50.0%
Q1 2020$525,000
-70.6%
30,600
-59.9%
0.00%
-60.0%
Q4 2019$1,783,000
+6.1%
76,386
+24.8%
0.01%0.0%
Q3 2019$1,681,000
-23.9%
61,200
-8.3%
0.01%
-16.7%
Q2 2019$2,209,000
-52.0%
66,762
-49.2%
0.01%
-57.1%
Q1 2019$4,606,000
+34.3%
131,461
+24.1%
0.01%
+40.0%
Q4 2018$3,430,000
-30.8%
105,972
+7.6%
0.01%
-9.1%
Q3 2018$4,959,000
+145.0%
98,502
+122.9%
0.01%
+120.0%
Q2 2018$2,024,0000.0%44,2000.0%0.01%0.0%
Q1 2018$2,024,000
-18.0%
44,200
-23.4%
0.01%
-58.3%
Q2 2017$2,469,000
-6.9%
57,700
-32.0%
0.01%
-14.3%
Q1 2017$2,653,000
+137.7%
84,900
+92.1%
0.01%
+180.0%
Q4 2016$1,116,000
-14.3%
44,200
-16.4%
0.01%
-16.7%
Q3 2016$1,302,000
-6.0%
52,872
-24.2%
0.01%
-25.0%
Q2 2016$1,385,00069,7830.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders